FOXM1 peptides and vaccines containing the same

Details for Australian Patent Application No. 2010216980 (hide)

Owner Oncotherapy Science, Inc.

Inventors Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko; Watanabe, Tomohisa

Agent Davies Collison Cave

Pub. Number AU-A-2010216980

PCT Pub. Number WO2010/095428

Priority 61/153,408 18.02.09 US

Filing date 17 February 2010

Wipo publication date 26 August 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

C12N 5/0784 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Dendritic cells

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

25 August 2011 PCT application entered the National Phase

  PCT publication WO2010/095428 Priority application(s): WO2010/095428

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010216990-Pearlitic rail with excellent wear resistance and toughness

2010216963-Recording medium, reproduction device, and integrated circuit